{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-090983","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.595314+00:00","generated_at":"2026-06-04T00:53:53.442262+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adaptive Biotechnologies appoints Kyle Piskel as CFO effective April 8, 2024","bullets":["Kyle Piskel promoted from Principal Accounting Officer to CFO; reports to CEO Chad Robins.","Base salary set at $380,000 per year; target bonus of 40% of eligible earnings.","Receives RSU grant of 31,260 shares (4-year vesting) and PSU grant of 75,000 shares (3-year performance period).","Also entitled to annual equity refresh of 43,740 RSUs, bringing 2024 total equity grants to 150,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-090983","json":"https://secwatch.observer/filing/0001193125-24-090983.json","markdown":"https://secwatch.observer/filing/0001193125-24-090983.md","text":"https://secwatch.observer/filing/0001193125-24-090983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/0001193125-24-090983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/d814314d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:53:53.442262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b79508bcb9","claim":"Kyle Piskel was appointed as Chief Financial Officer at Adaptive Biotechnologies Corp.","evidence_excerpt":"As previously announced, Adaptive Biotechnologies Corporation (the “ Company ”) appointed Kyle Piskel, the Company’s Principal Accounting Officer, to serve as its Chief Financial Officer effective April 8, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1478320/000119312524090983/0001193125-24-090983-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}